Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Roche Holdings ADR RHHBY

Healthcare

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue... see more

Add To Watchlist

Recent & Breaking News (OTCQX:RHHBY)

ACCU-CHEK® Aviva Expert, the first and only stand-alone blood glucose meter system with a built-in insulin calculator, is now available

PR Newswire September 16, 2014

World Health Organization recommends use of p16 IHC to help diagnose high-grade cervical disease

PR Newswire August 29, 2014

Seragon Pharmaceuticals Inc. Announces Closing of Its Acquisition by Genentech

GlobeNewswire August 27, 2014

Harwood Feffer LLP Announces Investigation of Intermune, Inc.

PR Newswire August 25, 2014

Spring Bioscience launches highly sensitive PD-L1 (SP142) antibody, a component of Roche's immunotherapy assay

PR Newswire August 25, 2014

Roche and InterMune Reach Definitive Merger Agreement

PR Newswire August 24, 2014

Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis

PR Newswire August 20, 2014

FDA Approves Genentech's Avastin Plus Chemotherapy for Treatment of Advanced Cervical Cancer

Business Wire August 14, 2014

Genentech Submits Supplemental Biologics License Application to FDA for Lucentis Indication in Diabetic Retinopathy

Business Wire August 8, 2014

Ventana paves the way for companion diagnostic early phase clinical trials in China to advance patient care

PR Newswire August 5, 2014

Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo

PR Newswire July 29, 2014

FDA Grants Genentech's Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer

Business Wire July 22, 2014

OTC Markets Group Announces Second Quarter Performance of OTCM ADR Index and OTCQX ADR 30 Index

PR Newswire July 17, 2014

FDA Grants Genentech's Avastin Priority Review for Certain Types of Cervical Cancer

Business Wire July 15, 2014

Genentech's Investigational Medicine Cobimetinib, Used in Combination with Zelboraf® (Vemurafenib), Helped People with Advanced Melanoma Live Significantly Longer Without Their Disease Worsening

Business Wire July 14, 2014

Merck Serono selects Ventana Medical Systems, Inc. to develop companion diagnostic test for its targeted cancer treatment

PR Newswire July 10, 2014

Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment

PR Newswire July 10, 2014

Seragon Pharmaceuticals Announces Acquisition Agreement With Genentech

GlobeNewswire July 2, 2014

Genentech Announces Definitive Agreement to Acquire Seragon Pharmaceuticals

Business Wire July 2, 2014

Immuno-Oncology Game-Changers from Big Pharma and Small Biotechs

Equities.com June 30, 2014